Assignee
MODRA PHARMACEUTICALS B V
NL·1 granted patent·4 pending applications·2 citations·filing 2019–2025
Top patents by PatentIndex Score
5 records- 0184US11571408B2Cancer treatment using docetaxel by controlling peak plasma levelsMODRA PHARMACEUTICALS B V·Filed 2022·Granted Feb 7, 2023·2 cites·13 claims
- 0261US2022079910A1Cancer Treatment Useing Docetaxel by Controlling Peak Plasma LevelsMODRA PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 0360US2025312305A1Cancer Treatment Using Docetaxel by Controlling Peak Plasma LevelsMODRA PHARMACEUTICALS B V·Filed 2025·Application pending·0 cites
- 0445US2022071944A1Combination Treatment for Solid Tumors Using Docetaxel and a CYP3A InhibitorMODRA PHARMACEUTICALS B V·Filed 2019·Application pending·0 cites
- 0542US2025144083A1Methods and compositions for treating cancer in taxane-resistant patientsMODRA PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →